RBM17 and acute myeloid leukemia: Among these direct NMD-sensitive splicing targets, the protein level of EIF4A2 is mostly differentially expressed upon RBM17 knockdown, therefore we aimed next to explore its function as a potential effector of RBM17 in AML.